(lp0
S"Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat Motley Fool - Feb 22, 2017 Momenta Pharmaceuticals  reported fourth-quarter earnings on Tuesday, but analysts weren't discussing the numbers.Momenta Delay Means Race For Copaxone Generic Is On - Seeking Alpha"
p1
aS'Why Momenta Pharmaceuticals, Inc. Stock Skyrocketed Higher Today Motley Fool - Jan 31, 2017 Shares of Momenta Pharmaceuticals  are up over 20% at 12:28 p.m. EST after the company announced that the U.S.Momenta Continues To Have A Lot Of Upside - Seeking Alpha'
p2
aS'Momenta Pharmaceuticals Appoints Scott M. Storer as Senior Vice President and ... GlobeNewswire  - Nov 2, 2016 CAMBRIDGE, Mass., Nov. 02, 2016  -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Scott M.Mylan, Momenta move ahead in trial for rheumatoid arthritis drug - Pittsburgh Business Times'
p3
aS'Stock Volatility Risk Alert: Momenta Pharmaceuticals Inc Price Volatility Hits ... CML News - 11 hours ago Before we cover the full analysis we make a quick alert here that Momenta Pharmaceuticals Inc  has seen its stock price whip around at an elevated level.'
p4
aS'Why Momenta Pharmaceuticals, Inc. Jumped Higher Today Motley Fool - Oct 11, 2016 Before then, it seems likely Momenta will try and partner M923 . Last month, Momenta announced that it will regain rights to the drug from Shire.A Compelling Risk/Reward Seen In Momenta Pharmaceuticals - BenzingaMomenta Pharmaceuticals  Stock Surges, Barclays Upgrades - TheStreet.com'
p5
aS'A Somewhat Murky Outlook For Momenta Pharmaceuticals Seeking Alpha - Dec 28, 2016 Although I have made some good gains from Momenta Pharmaceuticals over the past few months, it is one of the murkiest companies I follow in the biotech space.'
p6
aS"Tuesday's Market Insights: DryShips Inc. , Momenta Pharmaceuticals, Inc ... Smarter Analyst - Feb 21, 2017 Momenta Pharmaceuticals, Inc.  shares are trading down 14% after the complex pharmaceutical company announced that a warning letter had been delivered from the FDA to Pfizer, Sandoz's contracted manufacturer for Glatopa, a drug&nbsp;..."
p7
aS"Momenta Pharma shares halted as drug application hits speed bump MarketWatch - Feb 17, 2017 Momenta Pharmaceuticals Inc. MNTA, +2.21% were halted in the extended session Friday after the biotech company said a supplier's compliance issue could delay approval of a higher dose of one of its multiple sclerosis drugs.Momenta halted after noting compliance issue in drug application - Seeking Alpha"
p8
aS'Momenta Pharmaceuticals Appoints Corey N. Fishman to Board of Directors GlobeNewswire  - Sep 23, 2016 CAMBRIDGE, Mass., Sept. 23, 2016  -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Corey N.'
p9
aS'A Look Ahead For 2 Stocks: Momenta Pharmaceuticals, Inc. , Express, Inc ... Post Analyst - 19 hours ago Momenta Pharmaceuticals, Inc. has a consensus hold rating from 8 Wall Street analysts, and the number of shares currently sold short amount to at least 4.78% of shares outstanding.Next Weeks Broker Price Targets For Momenta Pharmaceuticals, Inc.  - Fiscal Standard'
p10
a.